An active compound in cannabis plants, once isolated, could be used to treat symptoms of schizophrenia according to findings of a new study.
Researchers at the Illawarra Health and Medical Research Institute (IHMRI) have been investigating what effect Cannabidiol has on the mental illness.
PhD candidate Ashleigh Osborne worked with a medical research team to make the findings explaining: “We wanted to see if Cannabidiol could alleviate the symptoms of schizophrenia that aren’t addressed by current antipsychotic drugs,” Ms Osborne said.
Ms Osborne said more research was needed before clinical trials could begin.
“This is the first study to prove Cannabidiol can be used to treat symptoms of schizophrenia that aren’t addressed by current medications,” she said.
“These findings are really promising but further research is needed to see if these findings translate to people suffering from schizophrenia.
Read the full article on four20.com.au